Yael Capital Management Limited appeared to be the VC, which was created in 2018.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Yael Capital Management Limited, startups are often financed by ZhenFund, Tencent Holdings, Sequoia Capital China. The meaningful sponsors for the fund in investment in the same round are SIG China (SIG Asia Investments), China Life Healthcare Fund.
Among the most popular portfolio startups of the fund, we may highlight XtalPi. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most successful fund investment fields, there are Pharmaceutical, Artificial Intelligence.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.
Related Funds
| Fund Name | Location |
| 10K Ventures | Berlin, Berlin, Germany |
| ABC Capital | Geneva, Geneve, Switzerland |
| Berkeley Angel Network | California, San Francisco, United States |
| BioMotiv | Cleveland, Ohio, United States |
| Daimler Trucks North America | Oregon, Portland, United States |
| Georgia State University | Atlanta, Georgia, United States |
| GrapeVine | China, Shanghai |
| GT Capital | China, Shanghai |
| Hardy Capital Partners | British Columbia, Canada, Vancouver |
| Jianzheng Touzi | China, Shanghai |
| Ludgate Environmental Fund | Kersey, Lancashire, United Kingdom |
| Major League Baseball Ventures | New York, New York, United States |
| Oval Park Capital | North Carolina, Raleigh, United States |
| Quality Jobs Fund (QJF) | - |
| RENN Capital | Dallas, Texas, United States |
| Rose Ventures | Madison, United States, Wisconsin |
| SalubrisBio | China, Guangdong, Shenzhen |
| Sejong Venture Partners | Fort Lee, New Jersey, United States |
| WeWork Creator Fund | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ReviR Therapeutics | $30M | 26 Jul 2024 | San Francisco, California, United States | ||
Xellar Biosystems | $15M | 17 Jul 2024 | Newton, Massachusetts, United States | ||
Recorna Bio | 28 Jun 2024 | Guangzhou, Guangdong, China | |||
Insight Technology | 22 Mar 2024 | Guangzhou, Guangdong, China | |||
Nafi Pharmaceuticals | 21 Sep 2023 | Shenzhen, Guangdong, China | |||
ynbiome | 19 Apr 2023 | Hangzhou, Zhejiang, China | |||
Regenerative Bio | $10M | 25 Feb 2022 | Cambridge, Massachusetts, United States | ||
Signet Therapeutics | $10M | 29 Oct 2021 | Newton, Massachusetts, United States | ||
Xbiome | 27 Nov 2020 | Futian District, Guangdong Province, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ReviR Therapeutics | $30M | 26 Jul 2024 | San Francisco, California, United States | ||
Xellar Biosystems | $15M | 17 Jul 2024 | Newton, Massachusetts, United States | ||
Recorna Bio | 28 Jun 2024 | Guangzhou, Guangdong, China | |||
Insight Technology | 22 Mar 2024 | Guangzhou, Guangdong, China | |||
Nafi Pharmaceuticals | 21 Sep 2023 | Shenzhen, Guangdong, China | |||
ynbiome | 19 Apr 2023 | Hangzhou, Zhejiang, China | |||
Regenerative Bio | $10M | 25 Feb 2022 | Cambridge, Massachusetts, United States | ||
Signet Therapeutics | $10M | 29 Oct 2021 | Newton, Massachusetts, United States | ||
Xbiome | 27 Nov 2020 | Futian District, Guangdong Province, China |
